Fitbit Joins the AFib Detection Crowd with New Clearance

The nod allows Google’s Fitbit to more effectively compete with the Apple Watch, which has had heart monitoring capabilities since 2018.

Omar Ford

April 13, 2022

1 Min Read
Image courtesy of Russell Hart / Alamy Stock Photo


Google’s Fitbit is the latest company to receive FDA clearance for a wearable to detect atrial fibrillation. Fitbit submitted its photoplethysmography algorithm to identify AFib for review last month.

The algorithm’s validation was supported by data from the Fitbit Heart Study, which was launched in May of 2020 and enrolled 455,699 participants over five months. The study was significant because it was one of the largest virtual studies of PPG-based software to date.

Data presented at the 2021 American Heart Association Scientific Sessions found that the Fitbit PPG detections correctly identified AFib episodes 98% of the time, as confirmed by ECG patch monitors.

The company follows in the footsteps of Apple, which won a nod from FDA for irregular heartbeat detection in 2018.  The clearance moved the needle – not in terms of innovation, but more so in terms of awareness. Apple’s clearance put a huge spotlight on atrial fibrillation.   







About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like